| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.00066 | 1 |